⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11555200 | 0.97 | ALDH1A1 (0.42) | — | |
| Oxalic Acid SCHEMBL11868511 | 0.93 | ALDH1A1 (0.39) | — | |
| SCHEMBL11067388 | 0.84 | ALDH1A1 (0.43) | — | |
| SCHEMBL11070602 | 0.83 | ALDH1A1 (0.39) | — | |
| SCHEMBL7566785 | 0.81 | ALDH1A1 (0.37) | — | |
| SCHEMBL4688117 | 0.81 | ALDH1A1 (0.46) | — | |
| SCHEMBL12191370 | 0.80 | LMNA (0.41) | — | |
| SCHEMBL1762048 | 0.80 | LMNA (0.41) | — | |
| SCHEMBL17797345 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL4955070 | 0.79 | ALDH1A1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112812113-B | Immunomodulatory compounds, compositions and uses thereof | 杭州和正医药有限公司 | 2022-09-20 | — | — | CN | disclosed |
| WO-2021093817-A1 | IMMUNOMODULATORY COMPOUNDS, COMPOSITION AND APPLICATION THEREOF | 杭州和正医药有限公司 | 2021-05-20 | — | — | WO | disclosed |
| EP-2028186-A2 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2009-02-25 | — | — | EP | disclosed |
| US-6235464-B1 | DETECTING VIRAL ANTIGEN IN LIQUID; MIXING VIRUS CONTAINING LIQUID WITH COATED MEMBRANES, SEPARATE MEMBRANE FROM LIQUID, INCUBATE MEMBRANE WITH TRACER, INCUBATE WITH A SECOND LIQUID CONTAINING SUBSTRATE FOR TRACER, DETECT VIRAL ANTIGEN | HENDERSON GLENN L (US) | 2001-05-22 | — | — | US | disclosed |
| EP-0633472-B1 | Immunoassay on a preblocked solid surface | BECTON DICKINSON CO (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0369361-B1 | Immunoassay on a preblocked solid surface | BECTON DICKINSON CO (US) | 1995-09-06 | — | — | EP | disclosed |
| EP-0369362-B1 | Substrate composition for alkaline phosphatase and method for assay using same | BECTON DICKINSON CO (US) | 1995-02-15 | — | — | EP | disclosed |
| EP-0633472-A2 | Immunoassay on a preblocked solid surface | Becton, Dickinson and Company (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5208143-A | Immunoassay on a preblocked solid surface | BECTON, DICKINSON AND COMPANY (US) | 1993-05-04 | — | — | US | disclosed |
| US-5135847-A | Levamisole as phosphatase inhibitor; immunoassay | BECTON, DICKINSON AND COMPANY (US) | 1992-08-04 | — | — | US | disclosed |
| US-5093231-A | Levamisole | BECTON, DICKINSON AND COMPANY (US) | 1992-03-03 | — | — | US | disclosed |
| EP-0369361-A2 | Immunoassay on a preblocked solid surface | Becton, Dickinson and Company (US) | 1990-05-23 | — | — | EP | disclosed |
| EP-0369362-A2 | Substrate composition for alkaline phosphatase and method for assay using same | Becton, Dickinson and Company (US) | 1990-05-23 | — | — | EP | disclosed |
| EP-0347256-A2 | Method for detecting a substance in a sample | TOSOH CORPORATION (JP) | 1989-12-20 | — | — | EP | disclosed |